{
  "DOI": "10.1186/s40246-023-00534-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00534-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003ePrimary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, with unclear pathogenesis. Although immune disorders, especially T cell infiltration, are thought to play a vital role in PSC, the specific pathogenesis mechanisms remain incompletely understood. This study evaluated the potential key gene associated with the PSC pathogenesis and analyzed the associations of the key gene with prognosis and immune cell infiltration by combining bioinformatics analysis and experimental verification.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eTranscriptome data of PSC and normal human liver tissues (GSE159676) were obtained from the gene expression omnibus database. Differentially expressed genes (DEGs) were identified, and differences in biological states were analyzed. A protein–protein interaction (PPI) network was constructed. Hub genes were identified, and their expression was verified using transcriptome data of mice fed 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and \u003cjats:italic\u003eMdr2\u003c/jats:italic\u003e\u003cjats:sup\u003e−/−\u003c/jats:sup\u003e mice (GSE179993, GSE80776), as well as by immunohistochemistry staining on clinical samples. The correlations between the key gene and other factors were evaluated by Pearson’s correlation coefficient. Immune cell infiltration into human liver (GSE159676) was analyzed by xCell and verified by immunofluorescence staining on PSC liver samples.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eOf the 185 DEGs identified, 113 were upregulated and 72 were downregulated genes in PSC. Genes associated with immune cell infiltration and fibrosis were significantly enriched in PSC. PPI network showed close interactions among DEGs. A module strongly associated with immune infiltration was identified, with annexin A1 (ANXA1) being the core gene. High expression of ANXA1 in PSC was confirmed in two public datasets and by immunohistochemistry staining on clinical samples. High ANXA1 expression was strongly associated with high-risk score for PSC. Also, ANXA1 expression was positively associated with chemokines and chemokine receptors and with the infiltration of immune cells, especially T cells, into liver with PSC. Immune infiltration, fibrosis, and cancer-related processes were markedly enriched in PSC with high expression of ANXA1.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eANXA1 is a key gene associated with high risk and infiltration of immune cells, especially T cells, in PSC. These findings provide new insight into the key biomarker of PSC and suggest that targeting ANXA1 may be a valuable strategy for the treatment of PSC.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "534"
  ],
  "article-number": "86",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "31 May 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "12 September 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "21 September 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study was approved by the Ethics Committee of Xiangya Hospital Central South University (No.202210226). The tissue samples involved in this study were from previous paraffin-embedded surgical or biopsy specimens derived from patients. All participants provided their written informed consent to participate in this study."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Jian",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Huiwen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Jinqing",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fu",
      "given": "Lei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Peng",
      "given": "Shifang",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        9,
        21
      ]
    ],
    "date-time": "2023-09-21T08:02:28Z",
    "timestamp": 1695283348000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        22
      ]
    ],
    "date-time": "2023-11-22T00:31:55Z",
    "timestamp": 1700613115000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "81974080",
        "82170640"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Natural Science Foundation of China"
    },
    {
      "award": [
        "2021039"
      ],
      "name": "WANG Bao-En Liver Fibrosis Research Fund"
    },
    {
      "award": [
        "2020SK30272"
      ],
      "name": "Research and Development Plan in Key Areas of Science and Technology Department of Hunan Province"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        24
      ]
    ],
    "date-time": "2024-03-24T15:53:39Z",
    "timestamp": 1711295619154
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        9,
        21
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            9,
            21
          ]
        ],
        "date-time": "2023-09-21T00:00:00Z",
        "timestamp": 1695254400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            9,
            21
          ]
        ],
        "date-time": "2023-09-21T00:00:00Z",
        "timestamp": 1695254400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00534-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00534-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00534-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        9,
        21
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        9,
        21
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(18)30300-3",
      "author": "JK Dyson",
      "doi-asserted-by": "crossref",
      "first-page": "2547",
      "issue": "10139",
      "journal-title": "Lancet",
      "key": "534_CR1",
      "unstructured": "Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391(10139):2547–59.",
      "volume": "391",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jhep.2011.10.025",
      "author": "K Boonstra",
      "doi-asserted-by": "crossref",
      "first-page": "1181",
      "issue": "5",
      "journal-title": "J Hepatol",
      "key": "534_CR2",
      "unstructured": "Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56(5):1181–8.",
      "volume": "56",
      "year": "2012"
    },
    {
      "DOI": "10.1002/hep.26565",
      "author": "K Boonstra",
      "doi-asserted-by": "crossref",
      "first-page": "2045",
      "issue": "6",
      "journal-title": "Hepatology",
      "key": "534_CR3",
      "unstructured": "Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58(6):2045–55.",
      "volume": "58",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0140-6736(13)60096-3",
      "author": "GM Hirschfield",
      "doi-asserted-by": "crossref",
      "first-page": "1587",
      "issue": "9904",
      "journal-title": "Lancet",
      "key": "534_CR4",
      "unstructured": "Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382(9904):1587–99.",
      "volume": "382",
      "year": "2013"
    },
    {
      "DOI": "10.1111/j.1478-3231.2008.01726.x",
      "author": "A Tanaka",
      "doi-asserted-by": "crossref",
      "first-page": "983",
      "issue": "7",
      "journal-title": "Liver Int",
      "key": "534_CR5",
      "unstructured": "Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int. 2008;28(7):983–9.",
      "volume": "28",
      "year": "2008"
    },
    {
      "DOI": "10.1002/jhbp.50",
      "author": "A Tanaka",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "issue": "1",
      "journal-title": "J Hepatobiliary Pancreat Sci",
      "key": "534_CR6",
      "unstructured": "Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2014;21(1):43–50.",
      "volume": "21",
      "year": "2014"
    },
    {
      "DOI": "10.14309/ajg.0000000000000268",
      "author": "RT Yokoda",
      "doi-asserted-by": "crossref",
      "first-page": "1593",
      "issue": "10",
      "journal-title": "Am J Gastroenterol",
      "key": "534_CR7",
      "unstructured": "Yokoda RT, Carey EJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Am J Gastroenterol. 2019;114(10):1593–605.",
      "volume": "114",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jhep.2012.04.015",
      "author": "R Adam",
      "doi-asserted-by": "crossref",
      "first-page": "675",
      "issue": "3",
      "journal-title": "J Hepatol",
      "key": "534_CR8",
      "unstructured": "Adam R, Karam V, Delvart V, O’Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57(3):675–88.",
      "volume": "57",
      "year": "2012"
    },
    {
      "DOI": "10.3748/wjg.v23.i14.2459",
      "author": "NG Gidwaney",
      "doi-asserted-by": "crossref",
      "first-page": "2459",
      "issue": "14",
      "journal-title": "World J Gastroenterol",
      "key": "534_CR9",
      "unstructured": "Gidwaney NG, Pawa S, Das KM. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World J Gastroenterol. 2017;23(14):2459–69.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S0009-9120(01)00215-6",
      "author": "RG Cameron",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "issue": "3",
      "journal-title": "Clin Biochem",
      "key": "534_CR10",
      "unstructured": "Cameron RG, Blendis LM, Neuman MG. Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem. 2001;34(3):195–201.",
      "volume": "34",
      "year": "2001"
    },
    {
      "DOI": "10.1053/j.gastro.2007.01.039",
      "author": "A Karrar",
      "doi-asserted-by": "crossref",
      "first-page": "1504",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "534_CR11",
      "unstructured": "Karrar A, Broomé U, Södergren T, Jaksch M, Bergquist A, Björnstedt M, et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology. 2007;132(4):1504–14.",
      "volume": "132",
      "year": "2007"
    },
    {
      "DOI": "10.1136/gut.49.1.131",
      "author": "X Bo",
      "doi-asserted-by": "crossref",
      "first-page": "131",
      "issue": "1",
      "journal-title": "Gut",
      "key": "534_CR12",
      "unstructured": "Bo X, Broome U, Remberger M, Sumitran-Holgersson S. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut. 2001;49(1):131–41.",
      "volume": "49",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.jhep.2017.07.022",
      "author": "TH Karlsen",
      "doi-asserted-by": "crossref",
      "first-page": "1298",
      "issue": "6",
      "journal-title": "J Hepatol",
      "key": "534_CR13",
      "unstructured": "Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis—a comprehensive review. J Hepatol. 2017;67(6):1298–323.",
      "volume": "67",
      "year": "2017"
    },
    {
      "DOI": "10.1007/BF00915293",
      "author": "L Si",
      "doi-asserted-by": "crossref",
      "first-page": "262",
      "issue": "4",
      "journal-title": "J Clin Immunol",
      "key": "534_CR14",
      "unstructured": "Si L, Whiteside TL, Schade RR, Starzl TE, Van Thiel DH. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol. 1984;4(4):262–72.",
      "volume": "4",
      "year": "1984"
    },
    {
      "DOI": "10.1126/scitranslmed.abb3107",
      "author": "CL Zimmer",
      "doi-asserted-by": "crossref",
      "first-page": "599",
      "journal-title": "Sci Transl Med",
      "key": "534_CR15",
      "unstructured": "Zimmer CL, von Seth E, Buggert M, Strauss O, Hertwig L, Nguyen S, et al. A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells. Sci Transl Med. 2021;13:599.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1016/S0025-6196(12)60897-0",
      "author": "E Hashimoto",
      "doi-asserted-by": "crossref",
      "first-page": "1049",
      "issue": "11",
      "journal-title": "Mayo Clin Proc",
      "key": "534_CR16",
      "unstructured": "Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc. 1993;68(11):1049–55.",
      "volume": "68",
      "year": "1993"
    },
    {
      "DOI": "10.1136/jcp.52.10.730",
      "author": "SM Cruickshank",
      "doi-asserted-by": "crossref",
      "first-page": "730",
      "issue": "10",
      "journal-title": "J Clin Pathol",
      "key": "534_CR17",
      "unstructured": "Cruickshank SM, Southgate J, Wyatt JI, Selby PJ, Trejdosiewicz LK. Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis. J Clin Pathol. 1999;52(10):730–4.",
      "volume": "52",
      "year": "1999"
    },
    {
      "DOI": "10.1189/jlb.5A1015-469R",
      "author": "T Schoknecht",
      "doi-asserted-by": "crossref",
      "first-page": "589",
      "issue": "2",
      "journal-title": "J Leukoc Biol",
      "key": "534_CR18",
      "unstructured": "Schoknecht T, Schwinge D, Stein S, Weiler-Normann C, Sebode M, Mucha S, et al. CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood. J Leukoc Biol. 2017;101(2):589–97.",
      "volume": "101",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.jhep.2016.12.001",
      "author": "D Schwinge",
      "doi-asserted-by": "crossref",
      "first-page": "798",
      "issue": "4",
      "journal-title": "J Hepatol",
      "key": "534_CR19",
      "unstructured": "Schwinge D, von Haxthausen F, Quaas A, Carambia A, Otto B, Glaser F, et al. Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related to IL-12 signaling. J Hepatol. 2017;66(4):798–805.",
      "volume": "66",
      "year": "2017"
    },
    {
      "DOI": "10.1002/hep.30061",
      "author": "AE Taylor",
      "doi-asserted-by": "crossref",
      "first-page": "1905",
      "issue": "5",
      "journal-title": "Hepatology",
      "key": "534_CR20",
      "unstructured": "Taylor AE, Carey AN, Kudira R, Lages CS, Shi T, Lam S, et al. Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis. Hepatology. 2018;68(5):1905–21.",
      "volume": "68",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jhep.2013.12.027",
      "author": "M Sebode",
      "doi-asserted-by": "crossref",
      "first-page": "1010",
      "issue": "5",
      "journal-title": "J Hepatol",
      "key": "534_CR21",
      "unstructured": "Sebode M, Peiseler M, Franke B, Schwinge D, Schoknecht T, Wortmann F, et al. Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. J Hepatol. 2014;60(5):1010–6.",
      "volume": "60",
      "year": "2014"
    },
    {
      "author": "Y Le",
      "first-page": "95",
      "issue": "2",
      "journal-title": "Cell Mol Immunol",
      "key": "534_CR22",
      "unstructured": "Le Y, Zhou Y, Iribarren P, Wang J. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol. 2004;1(2):95–104.",
      "volume": "1",
      "year": "2004"
    },
    {
      "DOI": "10.1084/jem.20041035",
      "author": "B Eksteen",
      "doi-asserted-by": "crossref",
      "first-page": "1511",
      "issue": "11",
      "journal-title": "J Exp Med",
      "key": "534_CR23",
      "unstructured": "Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hübscher SG, et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med. 2004;200(11):1511–7.",
      "volume": "200",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s00281-009-0167-2",
      "author": "AT Borchers",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "issue": "3",
      "journal-title": "Semin Immunopathol",
      "key": "534_CR24",
      "unstructured": "Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol. 2009;31(3):309–22.",
      "volume": "31",
      "year": "2009"
    },
    {
      "DOI": "10.1002/hep.31140",
      "author": "LK Kunzmann",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "issue": "4",
      "journal-title": "Hepatology",
      "key": "534_CR25",
      "unstructured": "Kunzmann LK, Schoknecht T, Poch T, Henze L, Stein S, Kriz M, et al. Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC). Hepatology. 2020;72(4):1310–26.",
      "volume": "72",
      "year": "2020"
    },
    {
      "DOI": "10.1002/hep.30470",
      "author": "CJ Soroka",
      "doi-asserted-by": "crossref",
      "first-page": "871",
      "issue": "3",
      "journal-title": "Hepatology",
      "key": "534_CR26",
      "unstructured": "Soroka CJ, Assis DN, Alrabadi LS, Roberts S, Cusack L, Jaffe AB, et al. Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile. Hepatology. 2019;70(3):871–82.",
      "volume": "70",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/gkq1184",
      "author": "T Barrett",
      "doi-asserted-by": "crossref",
      "first-page": "D1005",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res",
      "key": "534_CR27",
      "unstructured": "Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. NCBI GEO: archive for functional genomics data sets–10 years on. Nucleic Acids Res. 2011;39(Database issue):D1005–10.",
      "volume": "39",
      "year": "2011"
    },
    {
      "DOI": "10.2353/ajpath.2007.061133",
      "author": "P Fickert",
      "doi-asserted-by": "crossref",
      "first-page": "525",
      "issue": "2",
      "journal-title": "Am J Pathol",
      "key": "534_CR28",
      "unstructured": "Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol. 2007;171(2):525–36.",
      "volume": "171",
      "year": "2007"
    },
    {
      "DOI": "10.1053/j.gastro.2004.04.009",
      "author": "P Fickert",
      "doi-asserted-by": "crossref",
      "first-page": "261",
      "issue": "1",
      "journal-title": "Gastroenterology",
      "key": "534_CR29",
      "unstructured": "Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology. 2004;127(1):261–74.",
      "volume": "127",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.0506580102",
      "author": "A Subramanian",
      "doi-asserted-by": "crossref",
      "first-page": "15545",
      "issue": "43",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "534_CR30",
      "unstructured": "Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–50.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng1180",
      "author": "VK Mootha",
      "doi-asserted-by": "crossref",
      "first-page": "267",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "534_CR31",
      "unstructured": "Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73.",
      "volume": "34",
      "year": "2003"
    },
    {
      "DOI": "10.1186/s13059-017-1349-1",
      "author": "D Aran",
      "doi-asserted-by": "crossref",
      "first-page": "220",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "534_CR32",
      "unstructured": "Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.bbadis.2022.166556",
      "author": "H Wang",
      "doi-asserted-by": "crossref",
      "first-page": "166556",
      "issue": "12",
      "journal-title": "Biochim Biophys Acta Mol Basis Dis",
      "key": "534_CR33",
      "unstructured": "Wang H, Zhang J, Zhang X, Zhao N, Zhou Z, Tao L, et al. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfbeta1/Smad pathway in mice. Biochim Biophys Acta Mol Basis Dis. 2022;1868(12):166556.",
      "volume": "1868",
      "year": "2022"
    },
    {
      "DOI": "10.1016/S0025-6196(11)64614-4",
      "author": "WR Kim",
      "doi-asserted-by": "crossref",
      "first-page": "688",
      "issue": "7",
      "journal-title": "Mayo Clin Proc",
      "key": "534_CR34",
      "unstructured": "Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000;75(7):688–94.",
      "volume": "75",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.jhepr.2021.100328",
      "author": "G Fossdal",
      "doi-asserted-by": "crossref",
      "first-page": "100328",
      "issue": "5",
      "journal-title": "JHEP Rep",
      "key": "534_CR35",
      "unstructured": "Fossdal G, Mjelle AB, Wiencke K, Bjork I, Gilja OH, Folseraas T, et al. Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF. JHEP Rep. 2021;3(5):100328.",
      "volume": "3",
      "year": "2021"
    },
    {
      "DOI": "10.1002/jhbp.238",
      "author": "T Watanabe",
      "doi-asserted-by": "crossref",
      "first-page": "486",
      "issue": "6",
      "journal-title": "J Hepatobiliary Pancreat Sci",
      "key": "534_CR36",
      "unstructured": "Watanabe T, Hirano K, Tada M, Isayama H, Mizuno S, Arizumi T, et al. Short-term prognostic factors for primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2015;22(6):486–90.",
      "volume": "22",
      "year": "2015"
    },
    {
      "DOI": "10.2215/CJN.06230614",
      "author": "DR Mathern",
      "doi-asserted-by": "crossref",
      "first-page": "1636",
      "issue": "9",
      "journal-title": "Clin J Am Soc Nephrol",
      "key": "534_CR37",
      "unstructured": "Mathern DR, Heeger PS. Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol. 2015;10(9):1636–50.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1038/345212a0",
      "author": "MJ Crumpton",
      "doi-asserted-by": "crossref",
      "first-page": "212",
      "issue": "6272",
      "journal-title": "Nature",
      "key": "534_CR38",
      "unstructured": "Crumpton MJ, Dedman JR. Protein terminology tangle. Nature. 1990;345(6272):212.",
      "volume": "345",
      "year": "1990"
    },
    {
      "DOI": "10.1111/j.1476-5381.1988.tb11614.x",
      "author": "RJ Flower",
      "doi-asserted-by": "crossref",
      "first-page": "987",
      "issue": "4",
      "journal-title": "Br J Pharmacol",
      "key": "534_CR39",
      "unstructured": "Flower RJ. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol. 1988;94(4):987–1015.",
      "volume": "94",
      "year": "1988"
    },
    {
      "DOI": "10.1038/278456a0",
      "author": "RJ Flower",
      "doi-asserted-by": "crossref",
      "first-page": "456",
      "issue": "5703",
      "journal-title": "Nature",
      "key": "534_CR40",
      "unstructured": "Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979;278(5703):456–9.",
      "volume": "278",
      "year": "1979"
    },
    {
      "author": "M Perretti",
      "first-page": "60",
      "journal-title": "News Physiol Sci",
      "key": "534_CR41",
      "unstructured": "Perretti M, Gavins FN. Annexin 1: an endogenous anti-inflammatory protein. News Physiol Sci. 2003;18:60–4.",
      "volume": "18",
      "year": "2003"
    },
    {
      "DOI": "10.4049/jimmunol.178.7.4595",
      "author": "M Scannell",
      "doi-asserted-by": "crossref",
      "first-page": "4595",
      "issue": "7",
      "journal-title": "J Immunol",
      "key": "534_CR42",
      "unstructured": "Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C, et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol. 2007;178(7):4595–605.",
      "volume": "178",
      "year": "2007"
    },
    {
      "DOI": "10.1182/blood-2006-05-022798",
      "author": "F D'Acquisto",
      "doi-asserted-by": "crossref",
      "first-page": "1095",
      "issue": "3",
      "journal-title": "Blood",
      "key": "534_CR43",
      "unstructured": "D’Acquisto F, Merghani A, Lecona E, Rosignoli G, Raza K, Buckley CD, et al. Annexin-1 modulates T-cell activation and differentiation. Blood. 2007;109(3):1095–102.",
      "volume": "109",
      "year": "2007"
    },
    {
      "DOI": "10.1002/eji.200636792",
      "author": "F D'Acquisto",
      "doi-asserted-by": "crossref",
      "first-page": "3131",
      "issue": "11",
      "journal-title": "Eur J Immunol",
      "key": "534_CR44",
      "unstructured": "D’Acquisto F, Paschalidis N, Sampaio AL, Merghani A, Flower RJ, Perretti M. Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur J Immunol. 2007;37(11):3131–42.",
      "volume": "37",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0140-6736(10)60826-4",
      "author": "DL Scott",
      "doi-asserted-by": "crossref",
      "first-page": "1094",
      "issue": "9746",
      "journal-title": "Lancet",
      "key": "534_CR45",
      "unstructured": "Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–108.",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0002-9270(00)01059-5",
      "author": "HJ van Hoogstraten",
      "doi-asserted-by": "crossref",
      "first-page": "2015",
      "issue": "8",
      "journal-title": "Am J Gastroenterol",
      "key": "534_CR46",
      "unstructured": "van Hoogstraten HJ, Vleggaar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WC, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am J Gastroenterol. 2000;95(8):2015–22.",
      "volume": "95",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.pharmthera.2022.108163",
      "author": "X Liu",
      "doi-asserted-by": "crossref",
      "first-page": "108163",
      "journal-title": "Pharmacol Ther",
      "key": "534_CR47",
      "unstructured": "Liu X, Wang H, Liu X, Bridle K, Crawford D, Liang X. Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis. Pharmacol Ther. 2022;237:108163.",
      "volume": "237",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.molmed.2019.02.004",
      "author": "SL Foo",
      "doi-asserted-by": "crossref",
      "first-page": "315",
      "issue": "4",
      "journal-title": "Trends Mol Med",
      "key": "534_CR48",
      "unstructured": "Foo SL, Yap G, Cui J, Lim LHK. Annexin-A1—A blessing or a curse in cancer? Trends Mol Med. 2019;25(4):315–27.",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jaut.2015.08.016",
      "author": "GJ Webb",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "journal-title": "J Autoimmunol",
      "key": "534_CR49",
      "unstructured": "Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmunol. 2016;66:25–39.",
      "volume": "66",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41467-023-36678-8",
      "author": "Y Han",
      "doi-asserted-by": "crossref",
      "first-page": "1069",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "534_CR50",
      "unstructured": "Han Y, Byun J, Zhu C, Sun R, Roh JY, Cordell HJ, et al. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis. Nat Commun. 2023;14(1):1069.",
      "volume": "14",
      "year": "2023"
    },
    {
      "DOI": "10.1053/j.gastro.2009.11.046",
      "author": "TH Karlsen",
      "doi-asserted-by": "crossref",
      "first-page": "1102",
      "issue": "3",
      "journal-title": "Gastroenterology",
      "key": "534_CR51",
      "unstructured": "Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology. 2010;138(3):1102–11.",
      "volume": "138",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nrg1489",
      "author": "R Horton",
      "doi-asserted-by": "crossref",
      "first-page": "889",
      "issue": "12",
      "journal-title": "Nat Rev Genet",
      "key": "534_CR52",
      "unstructured": "Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5(12):889–99.",
      "volume": "5",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng.2616",
      "author": "JZ Liu",
      "doi-asserted-by": "crossref",
      "first-page": "670",
      "issue": "6",
      "journal-title": "Nat Genet",
      "key": "534_CR53",
      "unstructured": "Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet. 2013;45(6):670–5.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.4049/jimmunol.181.1.756",
      "author": "K Kurosu",
      "doi-asserted-by": "crossref",
      "first-page": "756",
      "issue": "1",
      "journal-title": "J Immunol",
      "key": "534_CR54",
      "unstructured": "Kurosu K, Takiguchi Y, Okada O, Yumoto N, Sakao S, Tada Y, et al. Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis. J Immunol. 2008;181(1):756–67.",
      "volume": "181",
      "year": "2008"
    },
    {
      "DOI": "10.1136/gutjnl-2016-313598",
      "author": "R Alberts",
      "doi-asserted-by": "crossref",
      "first-page": "1517",
      "issue": "8",
      "journal-title": "Gut",
      "key": "534_CR55",
      "unstructured": "Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, et al. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut. 2018;67(8):1517–24.",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1093/rheumatology/ken062",
      "author": "F D'Acquisto",
      "doi-asserted-by": "crossref",
      "first-page": "636",
      "issue": "5",
      "journal-title": "Rheumatology (Oxford)",
      "key": "534_CR56",
      "unstructured": "D’Acquisto F, Paschalidis N, Raza K, Buckley CD, Flower RJ, Perretti M. Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology (Oxford). 2008;47(5):636–9.",
      "volume": "47",
      "year": "2008"
    },
    {
      "DOI": "10.3748/wjg.v19.i16.2456",
      "author": "N Hongsrichan",
      "doi-asserted-by": "crossref",
      "first-page": "2456",
      "issue": "16",
      "journal-title": "World J Gastroenterol",
      "key": "534_CR57",
      "unstructured": "Hongsrichan N, Rucksaken R, Chamgramol Y, Pinlaor P, Techasen A, Yongvanit P, et al. Annexin A1: a new immunohistological marker of cholangiocarcinoma. World J Gastroenterol. 2013;19(16):2456–65.",
      "volume": "19",
      "year": "2013"
    },
    {
      "DOI": "10.1074/mcp.M115.054585",
      "author": "J Padden",
      "doi-asserted-by": "crossref",
      "first-page": "1072",
      "issue": "3",
      "journal-title": "Mol Cell Proteomics",
      "key": "534_CR58",
      "unstructured": "Padden J, Ahrens M, Kälsch J, Bertram S, Megger DA, Bracht T, et al. Immunohistochemical markers distinguishing cholangiocellular carcinoma (CCC) from pancreatic ductal adenocarcinoma (PDAC) discovered by proteomic analysis of microdissected cells. Mol Cell Proteomics. 2016;15(3):1072–82.",
      "volume": "15",
      "year": "2016"
    }
  ],
  "reference-count": 58,
  "references-count": 58,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00534-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}